A detailed history of New England Professional Planning Group Inc. transactions in Pfizer Inc stock. As of the latest transaction made, New England Professional Planning Group Inc. holds 42,206 shares of PFE stock, worth $1.17 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
42,206
Previous 46,260 8.76%
Holding current value
$1.17 Million
Previous $1.33 Million 12.02%
% of portfolio
0.61%
Previous 0.76%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$25.89 - $29.73 $104,958 - $120,525
-4,054 Reduced 8.76%
42,206 $1.17 Million
Q4 2023

Jan 10, 2024

SELL
$26.13 - $33.94 $158,269 - $205,574
-6,057 Reduced 11.58%
46,260 $1.33 Million
Q3 2023

Oct 10, 2023

SELL
$32.09 - $37.51 $170,782 - $199,628
-5,322 Reduced 9.23%
52,317 $1.74 Million
Q2 2023

Jul 20, 2023

BUY
$36.12 - $41.79 $650 - $752
18 Added 0.03%
57,639 $2.11 Million
Q1 2023

Apr 19, 2023

SELL
$39.39 - $51.28 $99,499 - $129,533
-2,526 Reduced 4.2%
57,621 $2.35 Million
Q4 2022

Jan 13, 2023

BUY
$41.75 - $54.5 $95,691 - $124,914
2,292 Added 3.96%
60,147 $0
Q3 2022

Oct 26, 2022

SELL
$43.76 - $53.42 $19,429 - $23,718
-444 Reduced 0.76%
57,855 $2.53 Million
Q2 2022

Jul 13, 2022

SELL
$46.53 - $55.17 $105,436 - $125,015
-2,266 Reduced 3.74%
58,299 $3.06 Million
Q1 2022

Apr 14, 2022

SELL
$45.75 - $56.69 $113,734 - $140,931
-2,486 Reduced 3.94%
60,565 $2.06 Million
Q4 2021

Feb 04, 2022

SELL
$41.32 - $61.25 $74,169 - $109,943
-1,795 Reduced 2.77%
63,051 $3.5 Million
Q3 2021

Nov 05, 2021

SELL
$39.25 - $50.42 $355,212 - $456,301
-9,050 Reduced 12.25%
64,846 $2.84 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $635,966 - $720,442
-17,710 Reduced 19.33%
73,896 $3.42 Million
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $134,160 - $151,306
-4,006 Reduced 4.19%
91,606 $3.59 Million
Q4 2020

Jan 29, 2021

SELL
$33.47 - $42.56 $863,124 - $1.1 Million
-25,788 Reduced 21.24%
95,612 $3.52 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $600,456 - $704,472
-18,912 Reduced 13.48%
121,400 $4.42 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $245,447 - $297,764
-8,149 Reduced 5.49%
140,312 $5.39 Million
Q1 2020

May 12, 2020

SELL
$27.03 - $38.62 $2.31 Million - $3.3 Million
-85,328 Reduced 36.5%
148,461 $5.59 Million
Q4 2019

Jan 15, 2020

BUY
$32.92 - $37.36 $556,084 - $631,085
16,892 Added 7.79%
233,789 $9.16 Million
Q3 2018

Nov 07, 2018

SELL
$34.47 - $41.81 $265,350 - $321,853
-7,698 Reduced 3.43%
216,897 $9.55 Million
Q2 2018

Aug 10, 2018

BUY
$32.98 - $35.16 $144,947 - $154,528
4,395 Added 2.0%
224,595 $8.16 Million
Q1 2018

May 02, 2018

SELL
$31.91 - $37.02 $436,975 - $506,951
-13,694 Reduced 5.85%
220,200 $8.06 Million
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $7.78 Million - $8.25 Million
233,894
233,894 $8.61 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $155B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track New England Professional Planning Group Inc. Portfolio

Follow New England Professional Planning Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Professional Planning Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Professional Planning Group Inc. with notifications on news.